We will only discuss NRF2 in the context of lung cancer in this paper, but many other mouse models, including colon, bladder, liver, and mammary, have demonstrated that a lack of NRF2 increases the potential for carcinogenesis [26–29]; this varies greatly in pulmonary neoplasias depending on the model tested. This evidence concerns the gene NFE2L2 and lung carcinoma.